scholarly article | Q13442814 |
P356 | DOI | 10.1074/JBC.M109.011841 |
P8608 | Fatcat ID | release_cj63qiqerbgn3gugjwsd23i3bi |
P932 | PMC publication ID | 2719316 |
P698 | PubMed publication ID | 19390118 |
P50 | author | Seon Hwa Lee | Q44225348 |
P2093 | author name string | Ian A Blair | |
Michelle V Williams | |||
Wenying Jian | |||
P2860 | cites work | 5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes | Q24320095 |
Biosynthesis and metabolism of leukotrienes | Q36876280 | ||
Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction | Q37045449 | ||
Lipid signalling in disease. | Q37064018 | ||
DNA adducts with lipid peroxidation products | Q37088744 | ||
Mast cells and inflammatory heart disease: potential drug targets | Q37108359 | ||
Expanding roles for leukotrienes in airway inflammation | Q37208991 | ||
Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development | Q37361326 | ||
Determination of cellular redox status by stable isotope dilution liquid chromatography/mass spectrometry analysis of glutathione and glutathione disulfide | Q40021502 | ||
A novel 4-oxo-2(E)-nonenal-derived endogenous thiadiazabicyclo glutathione adduct formed during cellular oxidative stress. | Q40123636 | ||
Translesion DNA Synthesis across the heptanone--etheno-2'-deoxycytidine adduct in cells | Q40242155 | ||
Mechanisms of free radical oxidation of unsaturated lipids | Q40443396 | ||
5-lipoxygenase antagonizes genotoxic stress-induced apoptosis by altering p53 nuclear trafficking | Q40514627 | ||
Expression of 5-lipoxygenase in lymphoblastoid B and T cells | Q41458439 | ||
Evidence for 5-lipoxygenase activity in human B cell lines. A possible role for arachidonic acid metabolites during B cell signal transduction | Q41739498 | ||
Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins | Q43642026 | ||
A novel lipid hydroperoxide-derived cyclic covalent modification to histone H4. | Q44557663 | ||
The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. | Q45025551 | ||
Overexpression of 5-lipoxygenase and cyclooxygenase 2 in hamster and human oral cancer and chemopreventive effects of zileuton and celecoxib | Q46365845 | ||
Induction of endothelial cell apoptosis by lipid hydroperoxide-derived bifunctional electrophiles. | Q46743266 | ||
Prospective study of 8-oxo-7,8-dihydro-2'-deoxyguanosine excretion and the risk of lung cancer | Q46859253 | ||
Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors. | Q53423897 | ||
Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents. | Q53430936 | ||
Expression of 5-lipoxygenase (5-LOX) in T lymphocytes. | Q53555004 | ||
MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes | Q67267224 | ||
Bacterial expression, purification and partial characterization of recombinant rabbit reticulocyte 15-lipoxygenase | Q70742571 | ||
Stereochemistry of oxygenation of linoleic acid catalyzed by prostaglandin-endoperoxide H synthase-2 | Q74113814 | ||
15-Lipoxygenation of phospholipids may precede the sn-2 cleavage by phospholipases A2: reaction specificities of secretory and cytosolic phospholipases A2 towards native and 15-lipoxygenated arachidonoyl phospholipids | Q77318013 | ||
Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance | Q24568279 | ||
5-Lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue | Q24685466 | ||
Cancer-related inflammation | Q27860907 | ||
Cyclooxygenase-2-mediated DNA damage | Q28181042 | ||
Targeted chiral lipidomics analysis | Q28187185 | ||
Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis | Q28205296 | ||
Accumulation of 8-oxo-deoxyguanosine in cardiovascular tissues with the development of hypertension | Q28571663 | ||
Lipoxygenase-5 is overexpressed in prostate adenocarcinoma | Q32159450 | ||
Protein adducts generated from products of lipid oxidation: focus on HNE and one. | Q33265402 | ||
Targeted lipidomics using electron capture atmospheric pressure chemical ionization mass spectrometry | Q33430358 | ||
Unexpected formation of etheno-2'-deoxyguanosine adducts from 5(S)-hydroperoxyeicosatetraenoic acid: evidence for a bis-hydroperoxide intermediate | Q33433071 | ||
Targeted chiral lipidomics analysis by liquid chromatography electron capture atmospheric pressure chemical ionization mass spectrometry (LC-ECAPCI/MS). | Q33438378 | ||
Lipoxygenase inhibitors as potential cancer chemopreventives | Q33647970 | ||
Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques | Q34145177 | ||
Lipid hydroperoxide-mediated DNA damage | Q34348782 | ||
Oxidative DNA damage and cardiovascular disease | Q34423098 | ||
Micronutrients: dietary intake v. supplement use. | Q34470904 | ||
The phospholipase A2 superfamily and its group numbering system | Q34566140 | ||
Cyclooxygenase-2-mediated metabolism of arachidonic acid to 15-oxo-eicosatetraenoic acid by rat intestinal epithelial cells | Q34696777 | ||
Leukotriene B4 receptor antagonists as therapeutics for inflammatory disease: preclinical and clinical developments | Q34718549 | ||
Regulation of enzymatic lipid peroxidation: the interplay of peroxidizing and peroxide reducing enzymes | Q34727520 | ||
Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs | Q34842453 | ||
Mammalian arachidonate 15-lipoxygenases structure, function, and biological implications | Q34997971 | ||
Coronary atherosclerosis and somatic mutations: an overview of the contributive factors for oxidative DNA damage. | Q35037752 | ||
Biological significance of phospholipid hydroperoxide glutathione peroxidase (PHGPx, GPx4) in mammalian cells | Q35042904 | ||
5-Lipoxygenase and atherosclerosis | Q35539445 | ||
5-Lipoxygenase: Cellular Biology and Molecular Pharmacology | Q35560651 | ||
Lipoxygenase pathways in atherogenesis | Q35840304 | ||
Arachidonic acid signaling in pathogenesis of allergy: therapeutic implications. | Q36107615 | ||
The role of leukotrienes in allergic rhinitis | Q36177570 | ||
The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis | Q36218949 | ||
The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets? | Q36533935 | ||
Five-lipoxygenase pathway of arachidonic acid metabolism in carcino-genesis and cancer chemoprevention | Q36651760 | ||
COX-2/5-LOX dual acting anti-inflammatory drugs in cancer chemotherapy. | Q36737980 | ||
P433 | issue | 25 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | DNA damage | Q5205747 |
P304 | page(s) | 16799-16807 | |
P577 | publication date | 2009-04-23 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | 5-Lipoxygenase-mediated endogenous DNA damage | |
P478 | volume | 284 |
Q34987471 | 15-oxo-Eicosatetraenoic acid, a metabolite of macrophage 15-hydroxyprostaglandin dehydrogenase that inhibits endothelial cell proliferation |
Q36076364 | 5-lipoxygenase mediates docosahexaenoyl ethanolamide and N-arachidonoyl-L-alanine-induced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cells |
Q37187622 | A broad-spectrum lipidomics screen of antiinflammatory drug combinations in human blood |
Q34225293 | Cyclooxygenase- and lipoxygenase-mediated DNA damage |
Q33747062 | Stable-isotope dilution LC–MS for quantitative biomarker analysis |
Q38222606 | Targeted chiral analysis of bioactive arachidonic Acid metabolites using liquid-chromatography-mass spectrometry |
Q33443229 | Targeted chiral lipidomics analysis of bioactive eicosanoid lipids in cellular systems |
Search more.